Learn More Breathe Better - A long-acting muscarinic antagonist (LAMA) is a medicine that may help control asthma long-term. Download this fact sheet to learn more about LAMAs and how they're used:
Aclidinium: A long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of COPD Stock Photo - Alamy
Mechanisms of action of LAMAs. ACh, acetylcholine; LAMA, longacting... | Download Scientific Diagram
![PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7a56c4ea6ccc14edcd10985bf0259da67b0b0376/13-Figure1-1.png "PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar")
PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar
Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram
Understanding the role of long-acting muscarinic antagonists in asthma treatment - ScienceDirect
Does my patient still need A long-acting inhaler? — PDC Rx
Combination therapy with long-acting bronchodilators and the risk of major adverse cardiovascular events in patients with COPD: a systematic review and meta-analysis | European Respiratory Society
Study design. Abbreviations: LAMA, long-acting muscarinic antagonist;... | Download Scientific Diagram
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
Long-Acting Dual Bronchodilators - LAMA/LABA Combo ... | GrepMed
Table 1 from Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar
Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
Navigating New Treatment Options for COPD | Consultant360
Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework | Respiratory Research | Full Text
Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD) - Horita, N - 2017 | Cochrane Library
LAMA - "Long-Acting Muscarinic Antagonists" by AcronymsAndSlang.com
Long-Acting Muscarinic Antagonists - LAMA (Anticholinergic) ... | GrepMed
Long-Acting Muscarinic Antagonists (LAMAs) Fact Sheet | NHLBI, NIH
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone
Long-Acting Muscarinic Antagonists (LAMAs) Fact Sheet | NHLBI, NIH
Soft-mist LAMA/LABA combination inhaler launched for COPD | MIMS online
New developments in inhaled therapy | Practice Nursing
Study design schematic. Abbreviations: LABA, long-actingβ 2 -agonist;... | Download Scientific Diagram
